CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 62 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $591,000 | -19.7% | 116,200 | 0.0% | 0.00% | – |
| Q2 2021 | $736,000 | -18.0% | 116,200 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $898,000 | +45.8% | 116,200 | +23.6% | 0.00% | – |
| Q4 2020 | $616,000 | +1.5% | 94,000 | +3.0% | 0.00% | – |
| Q3 2020 | $607,000 | -20.2% | 91,300 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $761,000 | +14.1% | 91,300 | +5.1% | 0.00% | 0.0% |
| Q1 2020 | $667,000 | -7.6% | 86,900 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $722,000 | +16.6% | 86,900 | +3.6% | 0.00% | 0.0% |
| Q3 2019 | $619,000 | -34.2% | 83,900 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $941,000 | +12.4% | 83,900 | +7.7% | 0.00% | 0.0% |
| Q1 2019 | $837,000 | -26.6% | 77,900 | +3.2% | 0.00% | 0.0% |
| Q4 2018 | $1,140,000 | -15.4% | 75,500 | +3.7% | 0.00% | -50.0% |
| Q3 2018 | $1,347,000 | -2.1% | 72,800 | +20.9% | 0.00% | 0.0% |
| Q2 2018 | $1,376,000 | +35.8% | 60,200 | +69.1% | 0.00% | +100.0% |
| Q1 2018 | $1,013,000 | +43.7% | 35,600 | +6.6% | 0.00% | 0.0% |
| Q4 2017 | $705,000 | +16.1% | 33,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $607,000 | +17.2% | 33,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $518,000 | +11.9% | 33,400 | +24.6% | 0.00% | 0.0% |
| Q1 2017 | $463,000 | +87.4% | 26,800 | +19.1% | 0.00% | – |
| Q4 2016 | $247,000 | -30.0% | 22,500 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $353,000 | +53.5% | 22,500 | 0.0% | 0.00% | – |
| Q2 2016 | $230,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,230,898 | $40,535,000 | 5.15% |
| Opaleye Management Inc. | 450,000 | $8,176,000 | 2.89% |
| EcoR1 Capital, LLC | 829,771 | $15,077,000 | 2.01% |
| Perceptive Advisors | 2,780,762 | $50,526,000 | 0.96% |
| Casdin Capital, LLC | 177,500 | $3,225,000 | 0.91% |
| Iguana Healthcare Management, LLC | 140,000 | $2,544,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 756,822 | $13,751,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $3,816,000 | 0.54% |
| HAMILTON LANE ADVISORS LLC | 28,346 | $515,000 | 0.35% |
| Tekla Capital Management LLC | 530,092 | $9,632,000 | 0.34% |